Geron (GERN)

Add to Watchlists
Create an Alert
2.11 -0.09  -4.09% NASDAQ Oct 17, 8:00PM BATS Real time Currency in USD
View Full Chart
GERN Price Chart
View All Events

GERN Events

Date Type Description
08/11/2014 13:30 PDT Misc Q2 2014 Geron Earnings Conference Call
08/11/2014 Earnings Q2 2014 Geron Earnings Result
07/22/2014 Spinoffs Ratio: 1058359:1000000
05/20/2014 Misc Annual General Meeting for Geron Corp
05/01/2014 16:30 EDT Misc Q1 2014 Geron Earnings Conference Call
05/01/2014 Earnings Q1 2014 Geron Earnings Result
03/12/2014 16:30 EDT Misc Q4 2013 Geron Corporation Earnings Conference Call
03/12/2014 Earnings Q4 2013 Geron Corporation Earnings Results
11/07/2013 16:30 EDT Misc Q3 2013 Geron Earnings Conference Call
11/07/2013 Earnings Q3 2013 Geron Earnings Results
View All Performance Charts

GERN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Geron is down 48.31% over the last year vs S&P 500 Total Return up 11.11%, Athersys down 27.47%, and Galena Biopharma down 15.65%.

Get Quote for
Advertisement

Portfolio Strategies Featuring GERN

Did Geron make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

GERN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.geron.com
  • IR Website: http://ir.geron.com/phoenix.zhtml?c=67323&p=irol-irhome
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: December 31, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Geron Corp is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic products for oncology such as telomerase inhibitor, imetelstat and in hematologic myeloid malignancies, among others.

GERN Excel Add-In Codes

  • Name: =YCI("GERN","name")
  • Description: =YCI("GERN","description")
  • Sector: =YCI("GERN","sector")
  • Industry: =YCI("GERN","industry")
  • Est. Current Fiscal Year End: =YCI("GERN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.